These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18476343)

  • 21. [Chiral separation of seven beta-blockers in the French pharmacopoeia].
    Berthault F; Kintz P; Mangin P
    Ann Pharm Fr; 1997; 55(1):12-9. PubMed ID: 9138317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
    Svendsen TL; Trap-Jensen J; Carlsen JE; McNair A
    Am Heart J; 1985 May; 109(5 Pt 2):1145-50. PubMed ID: 2859778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ozonation of reverse osmosis concentrate: kinetics and efficiency of beta blocker oxidation.
    Benner J; Salhi E; Ternes T; von Gunten U
    Water Res; 2008 Jun; 42(12):3003-12. PubMed ID: 18472125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a new degradation product of nifedipine formed on catalysis by atenolol: A typical case of alteration of degradation pathway of one drug by another.
    Handa T; Singh S; Singh IP
    J Pharm Biomed Anal; 2014 Feb; 89():6-17. PubMed ID: 24247088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatographic enantioseparation of three beta-adrenolytics using new derivatizing reagents synthesized from (S)-ketoprofen and confirmation of configuration of diastereomers.
    Alwera S; Bhushan R
    Biomed Chromatogr; 2016 Nov; 30(11):1772-1781. PubMed ID: 27129403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC.
    Prachi S; Komal C; Priti MJ
    AAPS PharmSciTech; 2017 Oct; 18(7):2410-2417. PubMed ID: 28155135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ¹³C cross-polarization magic-angle spinning nuclear magnetic resonance analysis of the solid drug forms with low concentration of an active ingredient-propranolol case.
    Pisklak DM; Zielińska-Pisklak M; Szeleszczuk L; Wawer I
    J Pharm Biomed Anal; 2014 May; 93():68-72. PubMed ID: 23911072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidation-coagulation of β-blockers by K2FeVIO4 in hospital wastewater: assessment of degradation products and biodegradability.
    Wilde ML; Mahmoud WM; Kümmerer K; Martins AF
    Sci Total Environ; 2013 May; 452-453():137-47. PubMed ID: 23500407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorimetric and solubility studies of nadolol and atenolol in SDS micelles.
    de Castro B; Gameiro P; Guimarães C; Lima JL; Reis S
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):573-7. PubMed ID: 9919957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative beta-adrenoceptor blocking effects of propranolol, bisoprolol, atenolol, acebutolol and diacetolol on the human isolated bronchus.
    Naline E; Sarria B; Ertzbischoff O; Ozanne P; Advenier C
    Br J Clin Pharmacol; 1990 Jul; 30(1):135-9. PubMed ID: 1975197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term stability characterization of a controlled release gastrointestinal therapeutic system coated with a cellulose acetate pseudolatex.
    Vaithiyalingam SR; Sastry SV; Dehon RH; Reddy IK; Khan MA
    Pharmazie; 2001 Jan; 56(1):66-9. PubMed ID: 11210674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenoceptor antagonists: studies on behaviour (delayed differentiation) in the monkey (Macaca mulatta).
    Nicholson AN; Wright CM
    Br J Pharmacol; 1980 Jan; 68(1):75-82. PubMed ID: 6101977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between the lipophilicity of some 1,4-piperazine derivatives of aryloxyaminopropanols and their beta-andrenolytic activity.
    Celková H; Cizmárik J; Mlynárová R; Hrobonová K; Lehotay J
    Acta Pol Pharm; 1998; 55(6):449-52. PubMed ID: 10073131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis.
    Zhang Y; Sun N; Jiang X; Xi Y
    J Am Soc Hypertens; 2017 Jul; 11(7):394-401. PubMed ID: 28760243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A degradation study of cefepime hydrochloride in solutions under various stress conditions by TLC-densitometry.
    Dąbrowska M; Starek M; Krzek J; Papp E; Król P
    Biomed Chromatogr; 2015 Mar; 29(3):388-95. PubMed ID: 25042047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
    Pringle TH; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of selected beta-blockers.
    Ogrodowczyk M; Marciniec B
    Acta Pol Pharm; 2013; 70(5):779-86. PubMed ID: 24147355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
    Telatyńska-Smieszek B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
    Pol Arch Med Wewn; 2004 Jan; 111(1):45-51. PubMed ID: 15088420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of beta-blockers in sewage treatment plants.
    Maurer M; Escher BI; Richle P; Schaffner C; Alder AC
    Water Res; 2007 Apr; 41(7):1614-22. PubMed ID: 17303212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of atenolol, metoprolol, and propranolol in postmortem human fluid and tissue specimens via LC/APCI-MS.
    Johnson RD; Lewis RJ
    Forensic Sci Int; 2006 Jan; 156(2-3):106-17. PubMed ID: 16410160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.